News
Ligand Pharmaceuticals (LGND) and Channel Therapeutics (CHRO) announced the signing of a definitive merger agreement to combine Ligand’s wholly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback